These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32776551)

  • 21. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.
    Ghayda RA; Lee J; Lee JY; Kim DK; Lee KH; Hong SH; Han YJ; Kim JS; Yang JW; Kronbichler A; Smith L; Koyanagi A; Jacob L; Shin JI
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32668763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of serum C-reactive protein (CRP) and D-dimer concentration on the severity of COVID-19 cases with or without diabetes: a systematic review and meta-analysis.
    Debi H; Itu ZT; Amin MT; Hussain F; Hossain MS
    Expert Rev Endocrinol Metab; 2022 Jan; 17(1):83-93. PubMed ID: 34781810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INR and COVID-19 severity and mortality: A systematic review with meta-analysis and meta-regression.
    Zinellu A; Paliogiannis P; Carru C; Mangoni AA
    Adv Med Sci; 2021 Sep; 66(2):372-380. PubMed ID: 34315012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
    Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
    Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation dysfunction is associated with severity of COVID-19: A meta-analysis.
    Zhu J; Pang J; Ji P; Zhong Z; Li H; Li B; Zhang J; Lu J
    J Med Virol; 2021 Feb; 93(2):962-972. PubMed ID: 32706396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19.
    Infante M; Pieri M; Lupisella S; D'Amore L; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Morello M
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):5889-5903. PubMed ID: 34661247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
    Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital.
    Sukrisman L; Sinto R
    J Int Med Res; 2021 Nov; 49(11):3000605211059939. PubMed ID: 34796762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis.
    Malik P; Patel U; Mehta D; Patel N; Kelkar R; Akrmah M; Gabrilove JL; Sacks H
    BMJ Evid Based Med; 2021 Jun; 26(3):107-108. PubMed ID: 32934000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
    Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated D-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    Shah S; Shah K; Patel SB; Patel FS; Osman M; Velagapudi P; Turagam MK; Lakkireddy D; Garg J
    Cardiol Rev; 2020; 28(6):295-302. PubMed ID: 33017364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?
    Katzenschlager S; Zimmer AJ; Gottschalk C; Grafeneder J; Schmitz S; Kraker S; Ganslmeier M; Muth A; Seitel A; Maier-Hein L; Benedetti A; Larmann J; Weigand MA; McGrath S; Denkinger CM
    PLoS One; 2021; 16(7):e0255154. PubMed ID: 34324560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis.
    Nugroho J; Wardhana A; Maghfirah I; Mulia EPB; Rachmi DA; A'yun MQ; Septianda I
    Int J Lab Hematol; 2021 Feb; 43(1):110-115. PubMed ID: 32931146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.